CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for C R Bard Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

C R Bard Inc
730 Central Ave
Phone: (908) 277-8000p:908 277-8000 MURRAY HILL, NJ  07974  United States Fax: (908) 277-8412f:908 277-8412

This company was Merged or Acquired on 12/29/2017.
This company ceased filing statements with the SEC on 1/8/2018.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Timothy M.Ring 64 8/8/2003 6/1/1992
President, Vice Chairman of the Board, Chief Operating Officer John H.Weiland 65 1/1/2016 3/1/1996
Group President James C.Beasley 53 7/22/2013 5/1/2009
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Angiomed GmbH
Bard Access Systems, Inc.
Bard Acquisition Sub, Inc.
113 additional Business Names available in full report.

General Information
Number of Employees: 16,300 (As of 12/31/2016)
Outstanding Shares: 72,892,372 (As of 9/30/2017)
Shareholders: 2,875
Stock Exchange: NYSE
Federal Tax Id: 221454160
Fax Number: (908) 277-8412


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, March 16, 2024